These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 35156451)
1. Twelve-Month Results of Tack-Optimized Balloon Angioplasty Using the Tack Endovascular System in Below-the-Knee Arteries (TOBA II BTK). Geraghty PJ; Adams GL; Schmidt A; Lichtenberg M; Wissgott C; Armstrong EJ; Hertting K; J Endovasc Ther; 2020 Aug; 27(4):626-636. PubMed ID: 35156451 [No Abstract] [Full Text] [Related]
2. Twenty-Four Month Results of Tack-Optimized Balloon Angioplasty Using the Tack Endovascular System in Below-the-Knee Arteries. Adams GL; Lichtenberg M; Wissgott C; Schmidt A; Tarra T; Matricardi S; Geraghty PJ J Endovasc Ther; 2023 Jun; 30(3):393-400. PubMed ID: 35352604 [TBL] [Abstract][Full Text] [Related]
3. Six-month pivotal results of tack optimized balloon angioplasty using the Tack Endovascular System in below-the-knee arteries. Geraghty PJ; Adams G; Schmidt A; J Vasc Surg; 2021 Mar; 73(3):918-929.e5. PubMed ID: 32956797 [TBL] [Abstract][Full Text] [Related]
4. Treatment of infrapopliteal post-PTA dissection with tack implants: 12-month results from the TOBA-BTK study. Brodmann M; Wissgott C; Holden A; Staffa R; Zeller T; Vasudevan T; Schneider P Catheter Cardiovasc Interv; 2018 Jul; 92(1):96-105. PubMed ID: 29573541 [TBL] [Abstract][Full Text] [Related]
5. Optimized drug-coated balloon angioplasty of the superficial femoral and proximal popliteal arteries using the Tack Endovascular System: Tack Optimized Balloon Angioplasty (TOBA) III 24-month results in standard and long lesions. Brodmann M; Wissgott C; Brechtel K; Lichtenberg M; Blessing E; Tarra T; Zeller T Catheter Cardiovasc Interv; 2023 Oct; 102(4):701-712. PubMed ID: 37560824 [TBL] [Abstract][Full Text] [Related]
6. Treating Post-Angioplasty Dissection in the Femoropopliteal Arteries Using the Tack Endovascular System: 12-Month Results From the TOBA II Study. Gray WA; Cardenas JA; Brodmann M; Werner M; Bernardo NI; George JC; Lansky A JACC Cardiovasc Interv; 2019 Dec; 12(23):2375-2384. PubMed ID: 31806218 [TBL] [Abstract][Full Text] [Related]
7. Results from the Tack Optimized Balloon Angioplasty (TOBA) study demonstrate the benefits of minimal metal implants for dissection repair after angioplasty. Bosiers M; Scheinert D; Hendriks JM; Wissgott C; Peeters P; Zeller T; Brodmann M; Staffa R; J Vasc Surg; 2016 Jul; 64(1):109-16. PubMed ID: 27139789 [TBL] [Abstract][Full Text] [Related]
8. Optimized drug-coated balloon angioplasty of the superficial femoral and proximal popliteal arteries using the Tack Endovascular System: TOBA III 12-month results. Brodmann M; Wissgott C; Brechtel K; Nikol S; Zeller T; Lichtenberg M; Blessing E; Gray W; J Vasc Surg; 2020 Nov; 72(5):1636-1647.e1. PubMed ID: 32414527 [TBL] [Abstract][Full Text] [Related]
9. MagicTouch PTA Sirolimus Coated Balloon for Femoropopliteal and Below the Knee Disease: Results From XTOSI Pilot Study Up To 12 Months. Choke E; Tang TY; Peh E; Damodharan K; Cheng SC; Tay JS; Finn AV J Endovasc Ther; 2022 Oct; 29(5):780-789. PubMed ID: 34911383 [TBL] [Abstract][Full Text] [Related]
10. Prospective Study of Serration Angioplasty in the Infrapopliteal Arteries Using the Serranator Device: PRELUDE BTK Study. Holden A; Lichtenberg M; Nowakowski P; Wissgott C; Hertting K; Brodmann M J Endovasc Ther; 2022 Aug; 29(4):586-593. PubMed ID: 34802313 [TBL] [Abstract][Full Text] [Related]
11. Temsirolimus Adventitial Delivery to Improve ANGiographic Outcomes Below the Knee. Cawich I; Armstrong EJ; George JC; Golzar J; Shishehbor MH; Razavi M; Lee V; Ouriel K J Endovasc Ther; 2024 Aug; 31(4):562-575. PubMed ID: 36320143 [TBL] [Abstract][Full Text] [Related]
12. Six-Month Angiographic and Clinical Outcomes of Therapeutic Ultrasound Pretreatment Associated With Plain Balloon Angioplasty for Below-the-Knee Lesions in Patients With Critical Limb Ischemia: A Prospective, Single-Center Pilot Study. Del Giudice C; Gandini R J Endovasc Ther; 2019 Apr; 26(2):191-198. PubMed ID: 30741077 [TBL] [Abstract][Full Text] [Related]
13. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial. Zeller T; Baumgartner I; Scheinert D; Brodmann M; Bosiers M; Micari A; Peeters P; Vermassen F; Landini M; Trials; 2014 Feb; 15():63. PubMed ID: 24552184 [TBL] [Abstract][Full Text] [Related]
14. "Ranger BTK" a Prospective Single-Centre Cohort Study on a New Drug-Coated Balloon for Below the Knee Lesions in Patients with Critical Limb Ischemia. Del Giudice C; Galloula A; Tiercelin C; Vilfaillot A; Alsac JM; Messas E; Déan CL; Larger E; Sapoval M Cardiovasc Intervent Radiol; 2021 Jul; 44(7):1017-1027. PubMed ID: 33948700 [TBL] [Abstract][Full Text] [Related]
15. Drug-Coated Balloon Angioplasty Compared With Uncoated Balloons in the Treatment of Infrapopliteal Artery Lesions (AcoArt II-BTK). Jia X; Zhuang B; Wang F; Gu Y; Zhang J; Lu X; Dai X; Liu Z; Bi W; Liu C; Wang S; Liistro F; Guo W J Endovasc Ther; 2021 Apr; 28(2):215-221. PubMed ID: 33118432 [TBL] [Abstract][Full Text] [Related]
16. Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia. Liistro F; Porto I; Angioli P; Grotti S; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L Circulation; 2013 Aug; 128(6):615-21. PubMed ID: 23797811 [TBL] [Abstract][Full Text] [Related]
17. Randomized Controlled Trial of Acotec Drug-Eluting Balloon Versus Plain Balloon for Below-the-Knee Angioplasty. Liistro F; Angioli P; Ventoruzzo G; Ducci K; Reccia MR; Ricci L; Falsini G; Scatena A; Pieroni M; Bolognese L JACC Cardiovasc Interv; 2020 Oct; 13(19):2277-2286. PubMed ID: 32950416 [TBL] [Abstract][Full Text] [Related]
18. Paclitaxel-coated balloons versus percutaneous transluminal angioplasty for infrapopliteal chronic total occlusions: the IN.PACT BTK randomised trial. Liistro F; Weinberg I; Almonacid Popma A; Shishehbor MH; Deckers S; Micari A EuroIntervention; 2022 Apr; 17(17):e1445-e1454. PubMed ID: 34602386 [TBL] [Abstract][Full Text] [Related]
19. Safety and Effectiveness of Passeo-18 Lux Drug-Coated Balloon Catheter in Infrainguinal Endovascular Revascularization in the Korean Population: A Multicenter Post-Market Surveillance Study. Choi TW; Won JH; Jae HJ; Jeon YS; Park SW; Ko GY; Yim NY; Won JY; Kim CW; Kim J Korean J Radiol; 2024 Jun; 25(6):565-574. PubMed ID: 38807338 [TBL] [Abstract][Full Text] [Related]
20. Six-Month Outcomes From the First-in-Human, Single-Arm SELUTION Sustained-Limus-Release Drug-Eluting Balloon Trial in Femoropopliteal Lesions. Zeller T; Brechtel K; Meyer DR; Noory E; Beschorner U; Albrecht T J Endovasc Ther; 2020 Oct; 27(5):683-690. PubMed ID: 32666871 [No Abstract] [Full Text] [Related] [Next] [New Search]